Results 151 to 160 of about 265,121 (267)
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Unveiling Dragon's Blood Radiation Mitigation Mechanism: Identifying Key Targets and Bioactive Compounds with Multiomics Using Integrated AI-Driven Models. [PDF]
Li B, Han C, Zhang H, Li B.
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Endoplasmic reticulum stress in non-small cell lung cancer: a review of therapeutic agents, mechanistic insights, and implications for therapy. [PDF]
Luo Q +6 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
INVESTIGATION OF THE STRUCTURE OF DETONATION COATINGS BASED ON CALCIUM PHOSPHATE COMPOUNDS
Zhuldyz Sagdoldina, Daryn Baizhan
openalex +2 more sources
Cuticular Permeability to Calcium Compounds in ‘Golden Delicious’ Apple Fruit [PDF]
Gregory M. Glenn, B. W. Poovaiah
openalex +1 more source
Computational drug repositioning approach to predict multi-target therapeutics for epilepsy. [PDF]
Kumar P +4 more
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source

